Mathers Edward T
Related Filers (16)
- SYNLOGIC, INC. (11)
- RHYTHM PHARMACEUTICALS, INC. (9)
- MEDIMMUNE INC /DE (8)
- Bright Health Group Inc. (7)
- Trevi Therapeutics, Inc. (7)
- Ra Pharmaceuticals, Inc. (5)
- Inozyme Pharma, Inc. (5)
- Reneo Pharmaceuticals, Inc. (4)
- Akouos, Inc. (4)
- Mirum Pharmaceuticals, Inc. (4)
- Senti Biosciences, Inc. (3)
- Liquidia Technologies Inc (2)
- Savara Inc (2)
- Monte Rosa Therapeutics, Inc. (2)
- ObsEva SA (1)
- Korro Bio, Inc. (1)
- Show More ...
Ownership (75)
4
Thursday, 12/21/2023
Bright Health Group Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 11/7/2023
Korro Bio, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 11/2/2023
Bright Health Group Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/19/2023
Bright Health Group Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/15/2023
Bright Health Group Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/19/2023
Savara Inc: Statement of changes in beneficial ownership of securities
4
Friday, 6/30/2023
Trevi Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/26/2023
SYNLOGIC, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 6/23/2023
RHYTHM PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/21/2023
Senti Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/15/2023
Inozyme Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/8/2023
Reneo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/6/2023
RHYTHM PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
3
Tuesday, 1/3/2023
ObsEva SA: Initial statement of beneficial ownership of securities
4
Friday, 12/2/2022
Akouos, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/19/2022
Bright Health Group Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/15/2022
Senti Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/27/2022
Akouos, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/23/2022
Trevi Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/15/2022
Senti Biosciences, Inc.\: Initial statement of beneficial ownership of securities
4
Tuesday, 6/14/2022
Inozyme Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/13/2022
SYNLOGIC, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 6/10/2022
RHYTHM PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 6/6/2022
Mirum Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/3/2022
Reneo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/13/2022
Trevi Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 1/5/2022
Bright Health Group Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 6/30/2021
Monte Rosa Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/25/2021
Akouos, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/24/2021
Bright Health Group Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 6/24/2021
Inozyme Pharma, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/23/2021
Monte Rosa Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 6/17/2021
Trevi Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4/A
Wednesday, 6/16/2021
RHYTHM PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 6/14/2021
SYNLOGIC, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 6/11/2021
RHYTHM PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/8/2021
Mirum Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/12/2021
Reneo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 4/8/2021
Reneo Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
3
Tuesday, 3/16/2021
Savara Inc: Initial statement of beneficial ownership of securities
4
Friday, 7/24/2020
Inozyme Pharma, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/23/2020
Inozyme Pharma, Inc.: Initial statement of beneficial ownership of securities
3
Thursday, 6/25/2020
Akouos, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 6/18/2020
RHYTHM PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 6/15/2020
Mirum Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/15/2020
Trevi Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/8/2020
SYNLOGIC, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 4/3/2020
Ra Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/17/2019
Mirum Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 6/21/2019
RHYTHM PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/13/2019
Ra Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/7/2019
SYNLOGIC, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/8/2019
Trevi Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 5/7/2019
Trevi Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 7/27/2018
Liquidia Technologies Inc: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/25/2018
Liquidia Technologies Inc: Initial statement of beneficial ownership of securities
4
Monday, 7/2/2018
Ra Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/14/2018
SYNLOGIC, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 6/8/2018
RHYTHM PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/3/2018
SYNLOGIC, INC.: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/4/2017
RHYTHM PHARMACEUTICALS, INC.: Initial statement of beneficial ownership of securities
4
Wednesday, 8/30/2017
SYNLOGIC, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/22/2017
Ra Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 10/25/2016
Ra Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 9/6/2016
Mirna Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 9/30/2015
Mirna Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 9/30/2015
Mirna Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/19/2007
MEDIMMUNE INC /DE: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/20/2007
MEDIMMUNE INC /DE: Statement of changes in beneficial ownership of securities
4
Thursday, 8/10/2006
MEDIMMUNE INC /DE: Statement of changes in beneficial ownership of securities
4
Monday, 2/27/2006
MEDIMMUNE INC /DE: Statement of changes in beneficial ownership of securities
4
Monday, 2/27/2006
MEDIMMUNE INC /DE: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/7/2006
MEDIMMUNE INC /DE: Statement of changes in beneficial ownership of securities
3/A
Friday, 9/9/2005
MEDIMMUNE INC /DE: Initial statement of beneficial ownership of securities
3
Tuesday, 5/31/2005
MEDIMMUNE INC /DE: Initial statement of beneficial ownership of securities